Tumor Ablation Market Report: Trends, Forecast and Competitive Analysis
In Progress. Get it in 2 to 4 weeks by ordering today
The future of the tumor ablation market looks promising with opportunities in liver, lung, kidney, bone metastasis, prostate, and breast applications. The global tumor ablation market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, and sprouting number of hospitalss, surgical, and ablation centers.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global tumor ablation market report, please download the report brochure.
In this market, microwave ablation is the largest technology segment of tumor ablation, whereas surgical ablation is the largest mode of treatment. Growth in various segments of the tumor ablation market are given below:
The study includes trends and forecast for the global tumor ablation market by technology, application, mode of treatment, end user, and region as follows:
By Technology [$M shipment analysis for 2014 – 2025]:
Radiofrequency (RF) AblationMicrowave AblationCryo AblationOther Technologies
By Application [$M shipment analysis for 2014 – 2025]:
LiverLung Kidney Bone MetastasisProstate Breast
By Mode of Treatment [$M shipment analysis for 2014 – 2025]:
Percutaneous AblationLaparoscopic AblationSurgical AblationLiver CancerLung CancerKidney CancerBone MetastasisOthers
By End User [$M shipment analysis for 2014 – 2025]:
HospitalsOncology Clinics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the tumor ablation companies profiled in this report include AngioDynamics, Boston Scientific, Galil Medical, EDAP TMS, Healthtronics, Medtronic, Mermaid Medical, Misonix, Neuwave Medical, and Sonacare Medical.
Lucintel forecasts that microwave ablation will remain the largest technology segment over the forecast period due to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.
Within this market, surgical ablation will remain the largest mode of treatment segment over the forecast period due to a large number of minimally invasive surgical procedures performed in mature markets to treat various cancers, growing market awareness of the benefits of surgical ablation in emerging markets, and large proportion of cancer patients ineligible for surgical cancer treatment.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to rising inclination of patients towards minimally invasive procedures for cancer treatment and increasing government funding for cancer research.
Features of the Global Tumor Ablation Market
Market Size Estimates: Global tumor ablation market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global tumor ablation market size by various segments, such as technology, application, mode of treatment, and end user in terms of value.Regional Analysis: Global tumor ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different technology, application, mode of treatment, end user, and region for the global tumor ablation market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global tumor ablation market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global tumor ablation market by technology (radiofrequency (RF) ablation, microwave ablation, cryo ablation and others), application (liver, lung, kidney, bone metastasis, prostate, and breast), mode of treatment (percutaneous ablation, laparoscopic ablation, surgical ablation, liver cancer, lung cancer, kidney cancer, bone metastasis and others), end user (hospitals and oncology clinics), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global tumor ablation market?
Q.5 What are the business risks and threats to the global tumor ablation market?
Q.6 What are the emerging trends in this tumor ablation market and the reasons behind them?
Q.7 What are some changing demands of customers in this tumor ablation market?
Q.8 What are the new developments in this tumor ablation market? Which companies are leading these developments?
Q.9 Who are the major players in this tumor ablation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this tumor ablation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global tumor ablation market?
The future of the tumor ablation market looks promising with opportunities in liver, lung, kidney, bone metastasis, prostate, and breast applications. The global tumor ablation market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, and sprouting number of hospitalss, surgical, and ablation centers.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global tumor ablation market report, please download the report brochure.
In this market, microwave ablation is the largest technology segment of tumor ablation, whereas surgical ablation is the largest mode of treatment. Growth in various segments of the tumor ablation market are given below:
The study includes trends and forecast for the global tumor ablation market by technology, application, mode of treatment, end user, and region as follows:
By Technology [$M shipment analysis for 2014 – 2025]:
Radiofrequency (RF) AblationMicrowave AblationCryo AblationOther Technologies
By Application [$M shipment analysis for 2014 – 2025]:
LiverLung Kidney Bone MetastasisProstate Breast
By Mode of Treatment [$M shipment analysis for 2014 – 2025]:
Percutaneous AblationLaparoscopic AblationSurgical AblationLiver CancerLung CancerKidney CancerBone MetastasisOthers
By End User [$M shipment analysis for 2014 – 2025]:
HospitalsOncology Clinics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the tumor ablation companies profiled in this report include AngioDynamics, Boston Scientific, Galil Medical, EDAP TMS, Healthtronics, Medtronic, Mermaid Medical, Misonix, Neuwave Medical, and Sonacare Medical.
Lucintel forecasts that microwave ablation will remain the largest technology segment over the forecast period due to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.
Within this market, surgical ablation will remain the largest mode of treatment segment over the forecast period due to a large number of minimally invasive surgical procedures performed in mature markets to treat various cancers, growing market awareness of the benefits of surgical ablation in emerging markets, and large proportion of cancer patients ineligible for surgical cancer treatment.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to rising inclination of patients towards minimally invasive procedures for cancer treatment and increasing government funding for cancer research.
Features of the Global Tumor Ablation Market
Market Size Estimates: Global tumor ablation market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global tumor ablation market size by various segments, such as technology, application, mode of treatment, and end user in terms of value.Regional Analysis: Global tumor ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different technology, application, mode of treatment, end user, and region for the global tumor ablation market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global tumor ablation market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global tumor ablation market by technology (radiofrequency (RF) ablation, microwave ablation, cryo ablation and others), application (liver, lung, kidney, bone metastasis, prostate, and breast), mode of treatment (percutaneous ablation, laparoscopic ablation, surgical ablation, liver cancer, lung cancer, kidney cancer, bone metastasis and others), end user (hospitals and oncology clinics), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global tumor ablation market?
Q.5 What are the business risks and threats to the global tumor ablation market?
Q.6 What are the emerging trends in this tumor ablation market and the reasons behind them?
Q.7 What are some changing demands of customers in this tumor ablation market?
Q.8 What are the new developments in this tumor ablation market? Which companies are leading these developments?
Q.9 Who are the major players in this tumor ablation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this tumor ablation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global tumor ablation market?
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Tumor Ablation Market Trends and Forecast
3.3: Global Tumor Ablation Market by Technology
3.3.1: Radiofrequency (RF) Ablation
3.3.2: Microwave Ablation
3.3.3: Cry Ablation
3.3.4: Others
3.4: Global Tumor Ablation Market by Application
3.4.1: Liver
3.4.2: Lung
3.4.3: Kidney
3.4.4: Bone Metastasis
3.4.5: Prostate
3.4.6: Breast
3.5: Global Tumor Ablation Market by Mode of Treatment
3.5.1: Percutaneous Ablation
3.5.2: Laparoscopic Ablation
3.5.3: Surgical Ablation
3.5.4: Liver Cancer
3.5.5: Lung Cancer
3.5.6: Kidney Cancer
3.5.7: Bone Metastasis
3.5.8: Others
3.6: Global Tumor Ablation Market by End User
3.6.1: Hospitals
3.6.2: Oncology Clinics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Tumor Ablation Market by Region
4.2: North American Tumor Ablation Market
4.2.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.2.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.2.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.2.4: Market by End User: Hospitals And Oncology Clinics
4.2.5: The United States Tumor Ablation Market
4.2.6: The Canadian Tumor Ablation Market
4.2.7: The Mexican Tumor Ablation Market
4.3: European Tumor Ablation Market
4.3.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.3.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.3.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.3.4: Market by End User: Hospitals And Oncology Clinics
4.3.5: The United Kingdom Tumor Ablation Market
4.3.6: The Spanish Tumor Ablation Market
4.3.7: The German Tumor Ablation Market
4.3.8: The French Tumor Ablation Market
4.4: APAC Tumor Ablation Market
4.4.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.4.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.4.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.4.4: Market by End User: Hospitals And Oncology Clinics
4.4.5: The Chinese Tumor Ablation Market
4.4.6: The Indian Tumor Ablation Market
4.4.7: The Japanese Tumor Ablation Market
4.5: ROW Tumor Ablation Market
4.5.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.5.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.5.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.5.4: Market by End User: Hospitals And Oncology Clinics
4.5.5: Brazilian Tumor Ablation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Tumor Ablation Market by Technology
7.1.2: Growth Opportunities for the Global Tumor Ablation Market by Application
7.1.3: Growth Opportunities for the Global Tumor Ablation Market by Mode of Treatment
7.1.4: Growth Opportunities for the Global Tumor Ablation Market by End User
7.1.5: Growth Opportunities for the Global Tumor Ablation Market by Region
7.2: Emerging Trends in the Global Tumor Ablation Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Tumor Ablation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tumor Ablation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: AngioDynamics
8.2: Boston Scientific
8.3: Galil Medical
8.4: EDAP TMS
8.5: Healthtronics
8.6: Medtronic
8.7: Mermaid Medical
8.8: Misonix
8.9: Neuwave Medical
8.10: Sonacare Medical
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Tumor Ablation Market Trends and Forecast
3.3: Global Tumor Ablation Market by Technology
3.3.1: Radiofrequency (RF) Ablation
3.3.2: Microwave Ablation
3.3.3: Cry Ablation
3.3.4: Others
3.4: Global Tumor Ablation Market by Application
3.4.1: Liver
3.4.2: Lung
3.4.3: Kidney
3.4.4: Bone Metastasis
3.4.5: Prostate
3.4.6: Breast
3.5: Global Tumor Ablation Market by Mode of Treatment
3.5.1: Percutaneous Ablation
3.5.2: Laparoscopic Ablation
3.5.3: Surgical Ablation
3.5.4: Liver Cancer
3.5.5: Lung Cancer
3.5.6: Kidney Cancer
3.5.7: Bone Metastasis
3.5.8: Others
3.6: Global Tumor Ablation Market by End User
3.6.1: Hospitals
3.6.2: Oncology Clinics
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Tumor Ablation Market by Region
4.2: North American Tumor Ablation Market
4.2.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.2.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.2.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.2.4: Market by End User: Hospitals And Oncology Clinics
4.2.5: The United States Tumor Ablation Market
4.2.6: The Canadian Tumor Ablation Market
4.2.7: The Mexican Tumor Ablation Market
4.3: European Tumor Ablation Market
4.3.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.3.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.3.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.3.4: Market by End User: Hospitals And Oncology Clinics
4.3.5: The United Kingdom Tumor Ablation Market
4.3.6: The Spanish Tumor Ablation Market
4.3.7: The German Tumor Ablation Market
4.3.8: The French Tumor Ablation Market
4.4: APAC Tumor Ablation Market
4.4.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.4.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.4.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.4.4: Market by End User: Hospitals And Oncology Clinics
4.4.5: The Chinese Tumor Ablation Market
4.4.6: The Indian Tumor Ablation Market
4.4.7: The Japanese Tumor Ablation Market
4.5: ROW Tumor Ablation Market
4.5.1: Market by Technology:Radiofrequency (RF) Ablation, Microwave Ablation, Cry Ablation and Others
4.5.2: Market by Application: Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast
4.5.3: Market by Mode of Treatment: Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others
4.5.4: Market by End User: Hospitals And Oncology Clinics
4.5.5: Brazilian Tumor Ablation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Tumor Ablation Market by Technology
7.1.2: Growth Opportunities for the Global Tumor Ablation Market by Application
7.1.3: Growth Opportunities for the Global Tumor Ablation Market by Mode of Treatment
7.1.4: Growth Opportunities for the Global Tumor Ablation Market by End User
7.1.5: Growth Opportunities for the Global Tumor Ablation Market by Region
7.2: Emerging Trends in the Global Tumor Ablation Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Tumor Ablation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tumor Ablation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: AngioDynamics
8.2: Boston Scientific
8.3: Galil Medical
8.4: EDAP TMS
8.5: Healthtronics
8.6: Medtronic
8.7: Mermaid Medical
8.8: Misonix
8.9: Neuwave Medical
8.10: Sonacare Medical
